CompanyGraph
Chongqing Xishan Science & Technology Co. Ltd.
688576 · SSE · China
xishantech.com.cnFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 10.59×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)
- FinancialsAltman Z-Score 11.01: safe zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.21%
Annual Rate
CNY 0.50Paid annual
Payout Ratio
92.6%High
Payback Period
82.3 yr
Last Ex-Dividend
Jun 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.78BCNY413.84M · vs all stocks (USD)
Trailing P/E
57.81xvs Medical Instruments & Supplies peers
Revenue (TTM)
347.94MCNY51.74M · vs all stocks (USD)
Profit Margin
13.71%vs Medical Instruments & Supplies peers
Beta
0.9900xvs all stocks
52-Week Change
-13.87%vs all stocks
Market Capitalization
2.78BCNY413.84M · vs all stocks (USD)
Enterprise Value
2.10BCNY312.21M · vs all stocks (USD)
Trailing P/E
57.81xvs Medical Instruments & Supplies peers
Forward P/E
9.33xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
8.20xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.64xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.03xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
42.64xvs Medical Instruments & Supplies peers
Gross Margin
62.15%vs Medical Instruments & Supplies peers
Profit Margin
13.71%vs Medical Instruments & Supplies peers
Operating Margin
7.02%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.76%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
2.75%vs Medical Instruments & Supplies peers
Revenue (TTM)
347.94MCNY51.74M · vs all stocks (USD)
Revenue per Share (TTM)
5.30CNYUpdated Aug 21, 2026Quarterly Revenue Growth
9.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
210.30MCNY31.27M · vs all stocks (USD)
EBITDA (TTM)
44.52MCNY6.62M · vs all stocks (USD)
Net Income (TTM)
47.72MCNY7.10M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-36.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
58.96MCNY8.77M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-587.05MCNY-87.30M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.5000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.21%vs all stocks
Payout Ratio
92.59%vs Medical Instruments & Supplies peers
Revenue
341.99MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
124.14MCNYFY2025 · Dec 31, 2025Gross Profit
217.85MCNYFY2025 · Dec 31, 2025Operating Income
40.33MCNY6.00M · vs all stocks (USD)
Pre-tax Income
53.09MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.18MCNYFY2025 · Dec 31, 2025Net Income
51.91MCNYFY2025 · Dec 31, 2025EBIT
40.33MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
69.93MCNYFY2025 · Dec 31, 2025Research & Development
58.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
56.35MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7718CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7718CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
67.25MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
67.25MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.91MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-18.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
-114.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
289.08MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.91MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.39MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-4.60MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-67.22MCNYFY2025 · Dec 31, 2025Capital Expenditures
-95.83MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.64BCNYFY2025 · Dec 31, 2025Sale of Investments
1.50BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-236.75MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-45.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
-47.20MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-92.39MCNYFY2025 · Dec 31, 2025Shares Outstanding
67.80MSharesUpdated Aug 21, 2026Float Shares
31.43MSharesUpdated Aug 21, 2026% Held by Insiders
60.83%vs all stocks
% Held by Institutions
7.35%vs all stocks
Total Cash (MRQ)
694.90MCNY103.34M · vs all stocks (USD)
Total Cash per Share (MRQ)
10.32CNYUpdated Aug 21, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
10.59xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
25.79CNYUpdated Aug 21, 2026Total Assets
1.90BCNY282.35M · vs all stocks (USD)
Total Current Assets
1.45BCNYFY2025 · Dec 31, 2025Total Liabilities
170.74MCNYFY2025 · Dec 31, 2025Total Non-current Assets
445.65MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.71MCNYFY2025 · Dec 31, 2025Total Current Liabilities
163.04MCNYFY2025 · Dec 31, 2025Cash
285.16MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.92MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
289.08MCNYFY2025 · Dec 31, 2025Other Short-term Investments
436.02MCNYFY2025 · Dec 31, 2025Accounts Receivable
39.05MCNYFY2025 · Dec 31, 2025Inventory
134.39MCNYFY2025 · Dec 31, 2025Accounts Payable
121.42MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.50MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.68MCNYFY2025 · Dec 31, 2025Common Stock (Book)
45.50MCNYFY2025 · Dec 31, 2025Retained Earnings
227.94MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.73BCNY256.96M · vs all stocks (USD)
Treasury Stock
23.61MCNYFY2025 · Dec 31, 202552-Week Low
34.83CNYUpdated Aug 21, 202652-Week High
58.83CNYUpdated Aug 21, 202652-Week Change
-13.87%vs all stocks
Beta
0.9900xvs all stocks
50-Day MA
41.33CNYUpdated Aug 21, 2026200-Day MA
46.21CNYUpdated Aug 21, 2026Avg 10-Day Volume
389.42KSharesUpdated Aug 21, 2026Avg 30-Day Volume
484.72KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.7300CNYUpdated Aug 21, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
How is this stock valued?
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 10.59×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 10.59Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Financial Health
Altman Z-Score 11.01: safe zoneNotable
Altman Z-Score: 11.01
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Mingxin New Material Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Suzhou Future Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Yanpai Filtration Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sekisui Jushi Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Meichen Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Wujin Stainless Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
BBK Test Systems Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiusheng Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
YG-1 Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tecnon Electronics Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Anhui XDLK Microsystems Co., Ltd.
6 interpretationsMinimal Tax and Interest DragPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And EquityMulti-Year Revenue And Profit Growth
Lontium Semiconductor Corp.
5 interpretationsMinimal Tax and Interest DragUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And EquityMulti-Year Revenue And Profit Growth
Shenzhen JDD Tech New Material Co., Ltd.
5 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And EquityMulti-Year Revenue And Profit Growth